Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 25

Publication Record

Connections

A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention.
Wei SC, Meijers WC, Axelrod ML, Anang NAS, Screever EM, Wescott EC, Johnson DB, Whitley E, Lehmann L, Courand PY, Mancuso JJ, Himmel LE, Lebrun-Vignes B, Wleklinski MJ, Knollmann BC, Srinivasan J, Li Y, Atolagbe OT, Rao X, Zhao Y, Wang J, Ehrlich LIR, Sharma P, Salem JE, Balko JM, Moslehi JJ, Allison JP
(2021) Cancer Discov 11: 614-625
MeSH Terms: Animals, Biomarkers, Tumor, Cardiotoxicity, Disease Management, Disease Models, Animal, Disease Susceptibility, Electrocardiography, Humans, Immune Checkpoint Inhibitors, Mice, Molecular Targeted Therapy, Myocarditis, Neoplasms
Added January 23, 2021
0 Communities
1 Members
0 Resources
13 MeSH Terms
Age-Related Considerations in Cardio-Oncology.
Screever EM, Meijers WC, Moslehi JJ
(2021) J Cardiovasc Pharmacol Ther 26: 103-113
MeSH Terms: Age Factors, Anthracyclines, Cardiology, Cardiotoxicity, Cardiovascular Diseases, Humans, Medical Oncology, Risk Factors
Added January 23, 2021
0 Communities
1 Members
0 Resources
8 MeSH Terms
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
Pudil R, Mueller C, Čelutkienė J, Henriksen PA, Lenihan D, Dent S, Barac A, Stanway S, Moslehi J, Suter TM, Ky B, Štěrba M, Cardinale D, Cohen-Solal A, Tocchetti CG, Farmakis D, Bergler-Klein J, Anker MS, Von Haehling S, Belenkov Y, Iakobishvili Z, Maack C, Ciardiello F, Ruschitzka F, Coats AJS, Seferovic P, Lainscak M, Piepoli MF, Chioncel O, Bax J, Hulot JS, Skouri H, Hägler-Laube ES, Asteggiano R, Fernandez TL, de Boer RA, Lyon AR
(2020) Eur J Heart Fail 22: 1966-1983
MeSH Terms: Antineoplastic Agents, Biomarkers, Tumor, Cardiotonic Agents, Cardiotoxicity, Heart Failure, Humans, Neoplasms
Added January 23, 2021
0 Communities
1 Members
0 Resources
7 MeSH Terms
Heart slice culture system reliably demonstrates clinical drug-related cardiotoxicity.
Miller JM, Meki MH, Ou Q, George SA, Gams A, Abouleisa RRE, Tang XL, Ahern BM, Giridharan GA, El-Baz A, Hill BG, Satin J, Conklin DJ, Moslehi J, Bolli R, Ribeiro AJS, Efimov IR, Mohamed TMA
(2020) Toxicol Appl Pharmacol 406: 115213
MeSH Terms: Adult, Aged, Animals, Antineoplastic Agents, Apoptosis, Cardiotoxicity, Cardiotoxins, Doxorubicin, Female, Heart, Humans, Induced Pluripotent Stem Cells, Male, Middle Aged, Models, Biological, Swine, Tissue Culture Techniques, Trastuzumab
Added September 29, 2020
0 Communities
1 Members
0 Resources
18 MeSH Terms
The cancer patient and cardiology.
Zamorano JL, Gottfridsson C, Asteggiano R, Atar D, Badimon L, Bax JJ, Cardinale D, Cardone A, Feijen EAM, Ferdinandy P, López-Fernández T, Gale CP, Maduro JH, Moslehi J, Omland T, Plana Gomez JC, Scott J, Suter TM, Minotti G
(2020) Eur J Heart Fail 22: 2290-2309
MeSH Terms: Aftercare, Antineoplastic Agents, Cardiotoxicity, Humans, Neoplasms, Radiotherapy, Risk Assessment, Risk Factors
Added September 29, 2020
0 Communities
1 Members
0 Resources
8 MeSH Terms
Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure.
Waliany S, Lee D, Witteles RM, Neal JW, Nguyen P, Davis MM, Salem JE, Wu SM, Moslehi JJ, Zhu H
(2021) Annu Rev Pharmacol Toxicol 61: 113-134
MeSH Terms: Cardiotoxicity, Cardiovascular System, Humans, Immune Checkpoint Inhibitors, Myocarditis, Neoplasms
Added September 29, 2020
0 Communities
1 Members
0 Resources
6 MeSH Terms
Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database.
Nguyen LS, Dolladille C, Drici MD, Fenioux C, Alexandre J, Mira JP, Moslehi JJ, Roden DM, Funck-Brentano C, Salem JE
(2020) Circulation 142: 303-305
MeSH Terms: Azithromycin, COVID-19, Cardiotoxicity, Databases, Factual, Electrocardiography, Heart Diseases, Humans, Hydroxychloroquine, Pharmacovigilance, Public Health Surveillance, World Health Organization
Added May 29, 2020
0 Communities
1 Members
0 Resources
11 MeSH Terms
Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses.
Hu JR, Duncan MS, Morgans AK, Brown JD, Meijers WC, Freiberg MS, Salem JE, Beckman JA, Moslehi JJ
(2020) Arterioscler Thromb Vasc Biol 40: e55-e64
MeSH Terms: Androgen Antagonists, Antineoplastic Agents, Hormonal, Cardiotoxicity, Cardiovascular Diseases, Cardiovascular System, Humans, Male, Prostatic Neoplasms, Risk Assessment, Risk Factors, Treatment Outcome
Added May 29, 2020
0 Communities
2 Members
0 Resources
11 MeSH Terms
Cancer Treatment-Associated Pericardial Disease: Epidemiology, Clinical Presentation, Diagnosis, and Management.
Ala CK, Klein AL, Moslehi JJ
(2019) Curr Cardiol Rep 21: 156
MeSH Terms: Antineoplastic Agents, Immunological, Cardiotoxicity, Cardiovascular Diseases, Humans, Immunotherapy, Neoplasms, Pericarditis, Pericardium, Risk Factors
Added January 15, 2020
0 Communities
1 Members
0 Resources
9 MeSH Terms
Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology.
Yeh ETH, Ewer MS, Moslehi J, Dlugosz-Danecka M, Banchs J, Chang HM, Minotti G
(2019) Semin Oncol 46: 397-402
MeSH Terms: Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Cardiotoxicity, Cardiovascular Diseases, DNA Topoisomerases, Type II, Humans, Medical Oncology, Molecular Targeted Therapy, Neoplasms, Poly-ADP-Ribose Binding Proteins
Added January 15, 2020
0 Communities
1 Members
0 Resources
10 MeSH Terms